Bank of America Corporation crossed the 5% threshold of voting rights in Lakefront Biotherapeutics on May 13, 2026, as reported on May 20. The bank now holds 623,434 direct voting rights and 5,502,802 equivalent financial instruments, totaling 9.3% of Lakefront's outstanding shares. This increase reflects Bank of America's strategic acquisition of voting rights and financial instruments, potentially influencing company decisions. Investors should watch for any future moves or impacts on Lakefront's governance and stock performance.
BacTech Environmental Corporation has updated its provisional Zero-Tailings™ patent application to include Reverse Osmosis and Mechanical Vapour Recompression technologies, aiming to improve the efficiency and energy use in producing specification-gr...
The VistaShares Target 15 Berkshire Select Income ETF (OMAH) provides exposure to Warren Buffett's stock picks combined with a covered call strategy to generate monthly income. It holds about 21 positions modeled after Berkshire Hathaway's portfolio,...
Cantor Fitzgerald analyst Thomas Blakey maintained a Neutral rating on Palantir stock, citing valuation concerns despite acknowledging the company's strong position in AI and stable growth. Palantir is seen as a leader in AI orchestration and has goo...
